Showing results (41-50 of 84) with videos related to
Sort By:
Pageof 9
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 15, 2011
Tumor-derived endothelial cells evade apoptotic activity of the interferon-inducible IFI16 geneFrancesca Gugliesi, Valentina Dell'oste, Marco De Andrea, et al.Journal of Virology|November 29, 2019
Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor GenesIrene Lo Cigno, Federica Calati, Cinzia Borgogna, et al.European Journal of Immunology|May 19, 2010
The interferon-inducible gene IFI16 secretome of endothelial cells drives the early steps of the inflammatory responseRossella Baggetta, Marco De Andrea, Grazia Rosaria Gariano, et al.Head & Neck|December 17, 2008
Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progressionMassimo Rittà, Marco De Andrea, Michele Mondini, et al.Virology|April 29, 2009
The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profilesBarbara Azzimonti, Valentina Dell'oste, Cinzia Borgogna, et al.The Journal of General Virology|September 18, 2008
Altered expression of UVB-induced cytokines in human papillomavirus-immortalized epithelial cellsValentina Dell'Oste, Barbara Azzimonti, Michele Mondini, et al.The New Microbiologica|May 21, 2013
Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancerMassimo Rittà, Vincenzo Landolfo, Jasenka Mazibrada, et al.Microorganisms|May 14, 2020
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus InfectionMatteo Biolatti, Marco Blangetti, Giulia D'Arrigo, et al.Journal of Virology|May 15, 2015
The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral PromotersIrene Lo Cigno, Marco De Andrea, Cinzia Borgogna, et al.Inflammatory Bowel Diseases|September 17, 2016
Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab TherapyValeria Caneparo, Luca Pastorelli, Laura Francesca Pisani, et al.Pageof 9